333 related articles for article (PubMed ID: 23801139)
1. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
[TBL] [Abstract][Full Text] [Related]
2. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
3. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
4. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
Awano N; Inomata M; Sonoda Y; Kondoh K; Ono R; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
J Clin Exp Hematop; 2013; 53(1):101-5. PubMed ID: 23801141
[No Abstract] [Full Text] [Related]
5. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
7. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
8. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab.
Kakiuchi S; Akiyama H; Harima I; Takagi I; Rikitake J; Kozuki Y; Inaba M; Fujiwara H; Kurose N; Yamada S; Masaki Y
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837418
[TBL] [Abstract][Full Text] [Related]
10. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
12. Tafro syndrome: Critical review for clinicians and pathologists.
Paydas S
Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
[TBL] [Abstract][Full Text] [Related]
13. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
14. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
[TBL] [Abstract][Full Text] [Related]
15. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
[TBL] [Abstract][Full Text] [Related]
16. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
[TBL] [Abstract][Full Text] [Related]
17. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
18. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
Takai K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
[TBL] [Abstract][Full Text] [Related]
19. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
[TBL] [Abstract][Full Text] [Related]
20. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
